Literature DB >> 32228322

COVID-19 pandemic, coronaviruses, and diabetes mellitus.

Ranganath Muniyappa1, Sriram Gubbi1.   

Abstract

The pandemic of coronavirus disease (COVID-19), a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is causing substantial morbidity and mortality. Older age and presence of diabetes mellitus, hypertension, and obesity significantly increases the risk for hospitalization and death in COVID-19 patients. In this Perspective, informed by the studies on SARS-CoV-2, Middle East respiratory syndrome (MERS-CoV), and the current literature on SARS-CoV-2, we discuss potential mechanisms by which diabetes modulates the host-viral interactions and host-immune responses. We hope to highlight gaps in knowledge that require further studies pertinent to COVID-19 in patients with diabetes.

Entities:  

Keywords:  COVID-19; coronavirus; diabetes mellitus

Mesh:

Year:  2020        PMID: 32228322      PMCID: PMC7191633          DOI: 10.1152/ajpendo.00124.2020

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  50 in total

1.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.

Authors:  Graziano Onder; Giovanni Rezza; Silvio Brusaferro
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

2.  Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

Authors:  Carlos M Ferrario; Jewell Jessup; Mark C Chappell; David B Averill; K Bridget Brosnihan; E Ann Tallant; Debra I Diz; Patricia E Gallagher
Journal:  Circulation       Date:  2005-05-16       Impact factor: 29.690

3.  Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse.

Authors:  Heleia Roca-Ho; Marta Riera; Vanesa Palau; Julio Pascual; Maria Jose Soler
Journal:  Int J Mol Sci       Date:  2017-03-05       Impact factor: 5.923

4.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Authors:  Xiaobo Yang; Yuan Yu; Jiqian Xu; Huaqing Shu; Jia'an Xia; Hong Liu; Yongran Wu; Lu Zhang; Zhui Yu; Minghao Fang; Ting Yu; Yaxin Wang; Shangwen Pan; Xiaojing Zou; Shiying Yuan; You Shang
Journal:  Lancet Respir Med       Date:  2020-02-24       Impact factor: 30.700

5.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Authors:  Roujian Lu; Xiang Zhao; Juan Li; Peihua Niu; Bo Yang; Honglong Wu; Wenling Wang; Hao Song; Baoying Huang; Na Zhu; Yuhai Bi; Xuejun Ma; Faxian Zhan; Liang Wang; Tao Hu; Hong Zhou; Zhenhong Hu; Weimin Zhou; Li Zhao; Jing Chen; Yao Meng; Ji Wang; Yang Lin; Jianying Yuan; Zhihao Xie; Jinmin Ma; William J Liu; Dayan Wang; Wenbo Xu; Edward C Holmes; George F Gao; Guizhen Wu; Weijun Chen; Weifeng Shi; Wenjie Tan
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

6.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

7.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.

Authors:  Stephen A Lauer; Kyra H Grantz; Qifang Bi; Forrest K Jones; Qulu Zheng; Hannah R Meredith; Andrew S Azman; Nicholas G Reich; Justin Lessler
Journal:  Ann Intern Med       Date:  2020-03-10       Impact factor: 25.391

8.  Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.

Authors:  A H Jan Danser; Murray Epstein; Daniel Batlle
Journal:  Hypertension       Date:  2020-03-25       Impact factor: 10.190

9.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Authors:  Markus Hoffmann; Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Tanja Herrler; Sandra Erichsen; Tobias S Schiergens; Georg Herrler; Nai-Huei Wu; Andreas Nitsche; Marcel A Müller; Christian Drosten; Stefan Pöhlmann
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582

10.  Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.

Authors:  Xin Zou; Ke Chen; Jiawei Zou; Peiyi Han; Jie Hao; Zeguang Han
Journal:  Front Med       Date:  2020-03-12       Impact factor: 4.592

View more
  224 in total

Review 1.  Dissecting the interaction between COVID-19 and diabetes mellitus.

Authors:  Ying Jie Chee; Seng Kiong Tan; Ester Yeoh
Journal:  J Diabetes Investig       Date:  2020-08-05       Impact factor: 4.232

Review 2.  [Obesity in the COVID era: A global health challenge].

Authors:  Miguel A Rubio Herrera; Irene Bretón Lesmes
Journal:  Endocrinol Diabetes Nutr       Date:  2020-10-21

3.  The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity.

Authors:  Hamid Bolouri; Cate Speake; David Skibinski; S Alice Long; Anne M Hocking; Daniel J Campbell; Jessica A Hamerman; Uma Malhotra; Jane H Buckner
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

4.  Inpatient Diabetes Management During the COVID-19 Crisis: Experiences From Two Community Hospitals.

Authors:  Carter Shelton; Andrew P Demidowich; Mihail Zilbermint
Journal:  J Diabetes Sci Technol       Date:  2020-06-02

5.  Sex Differences and COVID-19.

Authors:  Natalie Thomas; Caroline Gurvich; Jayashri Kulkarni
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Improved Detection of Abnormal Glucose Tolerance in Africans: The Value of Combining Hemoglobin A1c With Glycated Albumin.

Authors:  Arsene F Hobabagabo; Nana H Osei-Tutu; Thomas Hormenu; Elyssa M Shoup; Christopher W DuBose; Lilian S Mabundo; Joon Ha; Arthur Sherman; Stephanie T Chung; David B Sacks; Anne E Sumner
Journal:  Diabetes Care       Date:  2020-08-14       Impact factor: 19.112

7.  [Effect of hypertension on outcomes of patients with COVID-19].

Authors:  H U Chengyi; Xiao Lushan; Zhu Hongbo; Zhang Yanpei; Zhang Wenfeng; Liu Li; Zhu Hong
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-11-30

8.  Efficient Automated Disease Diagnosis Using Machine Learning Models.

Authors:  Naresh Kumar; Nripendra Narayan Das; Deepali Gupta; Kamali Gupta; Jatin Bindra
Journal:  J Healthc Eng       Date:  2021-05-04       Impact factor: 2.682

Review 9.  Crosstalk of TLR4, vascular NADPH oxidase, and COVID-19 in diabetes: What are the potential implications?

Authors:  Amanda Almeida de Oliveira; Kenia Pedrosa Nunes
Journal:  Vascul Pharmacol       Date:  2021-05-26       Impact factor: 5.773

Review 10.  The Weight of Obesity in Immunity from Influenza to COVID-19.

Authors:  Fernanda B Andrade; Ana Gualberto; Camila Rezende; Nathércia Percegoni; Jacy Gameiro; Eugenio D Hottz
Journal:  Front Cell Infect Microbiol       Date:  2021-03-17       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.